CAS: 2488788-52-7
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | RMC-0331 REF: 54-BUP07471CAS: 2488788-52-7 | 99.8% | 1,762.00 €~5,021.00 € | Mon 21 Apr 25 |
 | RMC-0331 REF: 3D-NZD78852CAS: 2488788-52-7 | Min. 95% | To inquire | Thu 29 May 25 |
 | RMC-0331 REF: TM-T38170CAS: 2488788-52-7 | 99.81% | 145.00 €~3,002.00 € | Thu 05 Jun 25 |
Ref: 54-BUP07471
| 25mg | 1,762.00 € | ||
| 50mg | 2,727.00 € | ||
| 100mg | 4,063.00 € | ||
| 200mg | 5,021.00 € |
Estimated delivery in United States, on Monday 21 Apr 2025
RMC-0331
CAS:2488788-52-7
Please enquire for more information about RMC-0331 including the price, delivery time and more detailed …
Formula:
C22H25ClF3N5O3
Purity:
Min. 95%
Molecular weight:
499.9 g/mol
Ref: 3D-NZD78852
| 10mg | 864.00 € | ||
| 25mg | 1,328.00 € | ||
| 50mg | 2,070.00 € |
Estimated delivery in United States, on Thursday 29 May 2025
RMC-0331
CAS:2488788-52-7
RMC-0331 (RM-023) is an oral SOS1 inhibitor with potential to block RAS activation and anticancer …
Formula:
C22H25ClF3N5O3
Purity:
99.81%
Color and Shape:
Solid
Molecular weight:
499.91
Ref: TM-T38170
| 1mg | 145.00 € | ||
| 2mg | 210.00 € | ||
| 5mg | 354.00 € | ||
| 10mg | 630.00 € | ||
| 25mg | 1,301.00 € |
Estimated delivery in United States, on Thursday 5 Jun 2025
